Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹-50 Cr₹-19 Cr₹12 Cr₹30 Cr₹41 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of NATCO PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of NATCO PHARMA is ₹-50 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹-50 Cr
Mar2024₹-19 Cr
Mar2023₹12 Cr
Mar2022₹30 Cr
Mar2021₹41 Cr

How is Deferred Tax Assets / Liabilities of NATCO PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹-50 Cr
Negative
Mar2024 ₹-19 Cr
Negative
Mar2023 ₹12 Cr
-58.80
Mar2022 ₹30 Cr
-27.12
Mar2021 ₹41 Cr -

Compare Deferred Tax Assets / Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,917.5 Cr 4.9% -23.1% -3.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,794.0 Cr 1.7% -2.3% 8% Stock Analytics
DIVIS LABORATORIES ₹178,956.0 Cr 2% -2.2% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,820.0 Cr -1.8% -0.1% 36.7% Stock Analytics
CIPLA ₹109,370.0 Cr -2% -3.3% -9.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,133.0 Cr -0.6% -3.8% -6.9% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

4.9%

-23.1%

-3.2%

SENSEX

1.7%

2.1%

-6%


You may also like the below Video Courses